Southpoint Capital Advisors LP

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 31% 68% 82%
Transactions
8 12% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 48%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Southpoint Capital Advisors LP's trades of Fennec Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-29 2025-12-24
S Sale
68,751 +3.3%
98.51
US$4,158,875 		68,751 +3.3% 98.51 US$4,158,875
2025-11-20 2025-11-18
S Sale
6,856 +18.7%
409.92
US$1,823,578 		6,856 +18.7% 409.92 US$1,823,578
2025-11-17 2025-11-17
S Sale
10,760 -49.6%
301.40
US$1,387,686 		10,760 -49.6% 301.40 US$1,387,686
2025-11-17 2025-11-14
S Sale
160,100 -4.0%
8.00
US$1,280,432 		160,100 -4.0% 8.00 US$1,280,432
2025-10-09 2025-10-09
S Sale
20,609 -0.5%
9.35
US$192,614 		20,609 -0.5% 9.35 US$192,614
2025-10-09 2025-10-08
S Sale
19,605 -0.5%
9.47
US$185,722 		19,605 -0.5% 9.47 US$185,722
2025-10-09 2025-10-07
S Sale
26,900 -0.7%
9.59
US$257,893 		26,900 -0.7% 9.59 US$257,893
2020-05-06 2020-05-04
B Purchase
80,000 +2.0%
6.25
US$500,000 		80,000 +2.0% 6.25 US$500,000